Michael B. Petras Jr. - 02 Mar 2025 Form 4 Insider Report for Sotera Health Co (SHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2025, 21:49:47 UTC
Prior SEC filing
22 Nov 2024
Next SEC filing
10 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Gregory S. Harvey, Attorney-in-Fact

Key filing fact

Michael B. Petras Jr. filed Form 4 for Sotera Health Co (SHC) on 04 Mar 2025.

Key facts

  • This page summarizes Michael B. Petras Jr.'s Form 4 filing for Sotera Health Co (SHC).
  • 5 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 04 Mar 2025, 21:49.

Change

  • Previous filing in this sequence was filed on 22 Nov 2024.
  • Current net transaction value: -$1,257,587.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SHC transaction

Common Stock, $0.01 par value per share ("Common Stock")

Tax liability

Transaction value
$349,035
Shares
-27,990
Change %
-4.2%
Price
$12.47
Shares after
642,509
Date
02 Mar 2025
Ownership
Direct
Footnotes
F1
SHC transaction

Common Stock

Tax liability

Transaction value
$397,444
Shares
-31,872
Change %
-5%
Price
$12.47
Shares after
610,637
Date
02 Mar 2025
Ownership
Direct
Footnotes
F2
SHC transaction

Common Stock

Tax liability

Transaction value
$511,108
Shares
-40,987
Change %
-6.7%
Price
$12.47
Shares after
569,650
Date
02 Mar 2025
Ownership
Direct
Footnotes
F3
SHC transaction

Common Stock

Award

Transaction value
$0
Shares
+298,953
Change %
+52%
Price
$0.000000
Shares after
868,603
Date
03 Mar 2025
Ownership
Direct
Footnotes
F4, F5
SHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,214,337
Date
02 Mar 2025
Ownership
By Grantor Trust
SHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
39,243
Date
02 Mar 2025
Ownership
By Family Trust
Footnotes
F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SHC transaction Derivative

Performance Stock Units

Award

Transaction value
$0
Shares
+149,476
Change %
Price
$0.000000
Shares after
149,476
Date
03 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
149,476
Exercise price
Footnotes
F7
SHC holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
544,509
Date
02 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
544,509
Exercise price
$14.59
Footnotes
F8, F9
SHC holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
404,094
Date
02 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
404,094
Exercise price
$17.59
Footnotes
F8, F10
SHC holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,108,356
Date
02 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,108,356
Exercise price
$6.37
Footnotes
F8, F11
SHC holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
478,932
Date
02 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
478,932
Exercise price
$20.03
Footnotes
F8, F12
SHC holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,118,012
Date
02 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,118,012
Exercise price
$23.00
Footnotes
F8, F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 62,407 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

Footnote F2

These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 71,063 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.

Footnote F3

These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 91,386 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 4, 2024. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to recieve one share of Common Stock, subject to vesting conditions.

Footnote F4

These securities consist of RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026.

Footnote F5

These securities consist of 552,790 RSUs and 315,813 shares of Common Stock.

Footnote F6

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F7

These securities consist of a maximum number of Performance Stock Units ("PSUs") that were granted on March 3, 2025, pursuant to the terms of a PSU agreement under the 2020 Incentive Plan. Each PSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The PSUs generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.

Footnote F8

No transaction is being reported on this line. Reported on a previously filed Form 4.

Footnote F9

These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.

Footnote F10

These options were granted on March 6, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2024, subject to vesting conditions.

Footnote F11

These options were granted on November 7, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three installments, as follows: 30%, 30%, and 40% of the options vest on each of the 12-month, 18-month, and 24-month anniversaries, respectively, of the date of grant, subject to the Reporting Person's continued service through each such date.

Footnote F12

These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

Footnote F13

These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in four equal installments on each of the first four anniversaries of the date of grant, subject to vesting conditions.

SEC remarks

The Power of Attorney for Mr. Petras is filed as an exhibit to the Form 4 filed on September 12, 2024, which is incorporated by reference.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .